← Back to opportunities

NHS National Framework for Transition products (Nilotinib and Ticagrelor)

NHS England

Buyer Contact Info

Buyer Name: NHS England

Buyer Address: Wellington House, 133-135 Waterloo Rd, London, UKI45, SE1 8UG, United Kingdom

Contact Email: katie.noonan@nhs.net

Status
complete
Procedure
open
Value
22097000.0 GBP
Published
20 Aug 2025, 07:17
Deadline
n/a
Contract Start
31 Aug 2025, 23:00
Contract End
31 Jan 2027, 23:59
Category
n/a
CPV
33600000 - Pharmaceutical products
Region
n/a
Awarded To
Zydus Pharmaceuticals UK Ltd, Accord-UK Ltd, AstraZeneca, Dr.Reddy's Laboratories (UK) Limited, MSN Laboratories Europe Limited, Novartis Pharmaceuticals UK Ltd, Zentiva Pharma UK Ltd
Official Source
Open Find a Tender

Description

Project title: NHS National Framework for Transition products (Nilotinib and Ticagrelor) commencing 1st September 2025 Offer reference number: CM/TNS/24/5721 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months. Potential periods of call-offs under the framework agreement: CM/TNS/24/5721/01 - Nilotinib and Ticagrelor Lot 1 DCE/DNW/DNE: 01/09/2025 to 31/01/2027 (17 months) Lot 2 DLN/DLS/DSW: 01/09/2025 to 31/01/2027 (17 months) Published By: Medicines Procurement and Supply Chain – NHS Medicines Value & Access, NHS England Please note that the contract had erroneously been advertised as an open framework at the tender stage and should have been advertised as a standalone framework. Additional Unsuccessful supplier not listed due to technical error: Torrent Pharma (UK) Ltd

Linked Documents

Select a document to preview.

Opportunity Context

Lots

Lot 1 Status: complete

Documents

Document Description: Not published

Contracts

Contract Title: NHS National Framework for Transition products (Nilotinib and Ticagrelor)

Raw Notice JSON

Expand raw payload
{
  "awards": [
    {
      "id": "1",
      "items": [
        {
          "additionalClassifications": [
            {
              "description": "Pharmaceutical products",
              "id": "33600000",
              "scheme": "CPV"
            }
          ],
          "id": "1",
          "relatedLot": "1"
        }
      ],
      "mainProcurementCategory": "goods",
      "relatedLots": [
        "1"
      ],
      "status": "active",
      "suppliers": [
        {
          "id": "GB-COH-14646636",
          "name": "Zydus Pharmaceuticals UK Ltd"
        },
        {
          "id": "GB-COH-00079585",
          "name": "Accord-UK Ltd"
        },
        {
          "id": "GB-COH-03674842",
          "name": "AstraZeneca"
        },
        {
          "id": "GB-COH-01729064",
          "name": "Dr.Reddy\u0027s Laboratories (UK) Limited"
        },
        {
          "id": "GB-COH-10185013",
          "name": "MSN Laboratories Europe Limited"
        },
        {
          "id": "GB-COH-00119006",
          "name": "Novartis Pharmaceuticals UK Ltd"
        },
        {
          "id": "GB-COH-02158996",
          "name": "Zentiva Pharma UK Ltd"
        }
      ]
    }
  ],
  "buyer": {
    "id": "GB-PPON-PDPT-3135-BWWY",
    "name": "NHS England"
  },
  "contracts": [
    {
      "aboveThreshold": true,
      "awardID": "1",
      "dateSigned": "2025-08-04T00:00:00+01:00",
      "documents": [
        {
          "documentType": "contractSigned",
          "format": "application/pdf",
          "id": "A-4406",
          "url": "https://www.find-tender.service.gov.uk/Notice/Attachment/A-4406"
        },
        {
          "datePublished": "2025-08-20T08:17:02+01:00",
          "description": "Contract details notice on Find a Tender",
          "documentType": "contractNotice",
          "format": "text/html",
          "id": "049985-2025",
          "noticeType": "UK7",
          "url": "https://www.find-tender.service.gov.uk/Notice/049985-2025"
        }
      ],
      "hasRenewal": true,
      "id": "1",
      "period": {
        "endDate": "2027-01-31T23:59:59Z",
        "maxExtentDate": "2029-01-31T23:59:59Z",
        "startDate": "2025-09-01T00:00:00+01:00"
      },
      "renewal": {
        "description": "option or options to extend (at the discretion of the Authority) up to maximum of 24 months."
      },
      "status": "active",
      "title": "NHS National Framework for Transition products (Nilotinib and Ticagrelor)",
      "value": {
        "amount": 22097000.0,
        "amountGross": 26516400.0,
        "currency": "GBP"
      }
    }
  ],
  "date": "2025-08-20T08:17:02+01:00",
  "id": "049985-2025",
  "initiationType": "tender",
  "language": "en",
  "ocid": "ocds-h6vhtk-04ff90",
  "parties": [
    {
      "address": {
        "country": "GB",
        "countryName": "United Kingdom",
        "locality": "London",
        "postalCode": "SE1 8UG",
        "region": "UKI45",
        "streetAddress": "Wellington House, 133-135 Waterloo Rd"
      },
      "contactPoint": {
        "email": "katie.noonan@nhs.net"
      },
      "details": {
        "classifications": [
          {
            "description": "Public authority - central government",
            "id": "publicAuthorityCentralGovernment",
            "scheme": "UK_CA_TYPE"
          }
        ],
        "url": "https://www.england.nhs.uk/"
      },
      "id": "GB-PPON-PDPT-3135-BWWY",
      "identifier": {
        "id": "PDPT-3135-BWWY",
        "scheme": "GB-PPON"
      },
      "name": "NHS England",
      "roles": [
        "buyer"
      ]
    },
    {
      "address": {
        "country": "GB",
        "countryName": "United Kingdom",
        "locality": "Bristol",
        "postalCode": "BS1 6FL",
        "region": "UKK11",
        "streetAddress": "First Floor Templeback"
      },
      "contactPoint": {
        "email": "josh.ferguson@zydusuk.com"
      },
      "details": {
        "publicServiceMissionOrganization": false,
        "scale": "sme",
        "shelteredWorkshop": false,
        "vcse": false
      },
      "id": "GB-COH-14646636",
      "identifier": {
        "id": "14646636",
        "scheme": "GB-COH"
      },
      "name": "Zydus Pharmaceuticals UK Ltd",
      "roles": [
        "supplier"
      ]
    },
    {
      "address": {
        "country": "GB",
        "countryName": "United Kingdom",
        "locality": "Devon",
        "postalCode": "EX32 8NS",
        "region": "UKK43",
        "streetAddress": "Whiddon Valley"
      },
      "contactPoint": {
        "email": "hospmsg@accord-healthcare.com"
      },
      "details": {
        "publicServiceMissionOrganization": false,
        "scale": "large",
        "shelteredWorkshop": false,
        "vcse": false
      },
      "id": "GB-COH-00079585",
      "identifier": {
        "id": "00079585",
        "scheme": "GB-COH"
      },
      "name": "Accord-UK Ltd",
      "roles": [
        "supplier"
      ]
    },
    {
      "address": {
        "country": "GB",
        "countryName": "United Kingdom",
        "locality": "London",
        "postalCode": "N1C 4AG",
        "region": "UKI31",
        "streetAddress": "2 Pancras Sq"
      },
      "contactPoint": {
        "email": "roman.rojik@astrazeneca.com"
      },
      "details": {
        "publicServiceMissionOrganization": false,
        "scale": "large",
        "shelteredWorkshop": false,
        "vcse": false
      },
      "id": "GB-COH-03674842",
      "identifier": {
        "id": "03674842",
        "scheme": "GB-COH"
      },
      "name": "AstraZeneca",
      "roles": [
        "supplier"
      ]
    },
    {
      "address": {
        "country": "GB",
        "countryName": "United Kingdom",
        "locality": "Cambridge",
        "postalCode": "CB4 0PE",
        "region": "UKH12",
        "streetAddress": "410 Cambridge Science Park Milton Road"
      },
      "contactPoint": {
        "email": "drlukhospital@drreddys.com"
      },
      "details": {
        "publicServiceMissionOrganization": false,
        "scale": "sme",
        "shelteredWorkshop": false,
        "vcse": false
      },
      "id": "GB-COH-01729064",
      "identifier": {
        "id": "01729064",
        "scheme": "GB-COH"
      },
      "name": "Dr.Reddy\u0027s Laboratories (UK) Limited",
      "roles": [
        "supplier"
      ]
    },
    {
      "address": {
        "country": "GB",
        "countryName": "United Kingdom",
        "locality": "Hitchin",
        "postalCode": "SG4 0TY",
        "region": "UKH23",
        "streetAddress": "Invision House"
      },
      "contactPoint": {
        "email": "jocelyn.ligas@msnlabs.com"
      },
      "details": {
        "publicServiceMissionOrganization": false,
        "scale": "large",
        "shelteredWorkshop": false,
        "vcse": false
      },
      "id": "GB-COH-10185013",
      "identifier": {
        "id": "10185013",
        "scheme": "GB-COH"
      },
      "name": "MSN Laboratories Europe Limited",
      "roles": [
        "supplier"
      ]
    },
    {
      "address": {
        "country": "GB",
        "countryName": "United Kingdom",
        "locality": "London",
        "postalCode": "W12 7FQ",
        "region": "UKI33",
        "streetAddress": "2nd Floor, The WestWorks Building, White City Place, 195 Wood Lane,"
      },
      "contactPoint": {
        "email": "commercial.pricing@novartis.com"
      },
      "details": {
        "publicServiceMissionOrganization": false,
        "scale": "large",
        "shelteredWorkshop": false,
        "vcse": false
      },
      "id": "GB-COH-00119006",
      "identifier": {
        "id": "00119006",
        "scheme": "GB-COH"
      },
      "name": "Novartis Pharmaceuticals UK Ltd",
      "roles": [
        "supplier"
      ]
    },
    {
      "address": {
        "country": "GB",
        "countryName": "United Kingdom",
        "locality": "London",
        "postalCode": "EC4A 1JP",
        "region": "UKI31",
        "streetAddress": "12 New Fetter Lane"
      },
      "contactPoint": {
        "email": "ukcustomerservices@zentiva.com"
      },
      "details": {
        "publicServiceMissionOrganization": false,
        "scale": "large",
        "shelteredWorkshop": false,
        "vcse": false
      },
      "id": "GB-COH-02158996",
      "identifier": {
        "id": "02158996",
        "scheme": "GB-COH"
      },
      "name": "Zentiva Pharma UK Ltd",
      "roles": [
        "supplier"
      ]
    }
  ],
  "tag": [
    "award",
    "contract"
  ],
  "tender": {
    "coveredBy": [
      "GPA"
    ],
    "description": "Project title: NHS National Framework for Transition products (Nilotinib and Ticagrelor) commencing 1st September 2025\nOffer reference number: CM/TNS/24/5721\nPeriod of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months.\nPotential periods of call-offs under the framework agreement:\nCM/TNS/24/5721/01 - Nilotinib and Ticagrelor\nLot 1 DCE/DNW/DNE: 01/09/2025 to 31/01/2027 (17 months)\nLot 2 DLN/DLS/DSW: 01/09/2025 to 31/01/2027 (17 months)\nPublished By: Medicines Procurement and Supply Chain \u2013 NHS Medicines Value \u0026 Access, NHS England\nPlease note that the contract had erroneously been advertised as an open framework at the tender stage and should have been advertised as a standalone framework.\nAdditional Unsuccessful supplier not listed due to technical error:\nTorrent Pharma (UK) Ltd",
    "documents": [
      {
        "description": "Not published",
        "documentType": "conflictOfInterest",
        "id": "conflictOfInterest"
      }
    ],
    "id": "C352808",
    "legalBasis": {
      "id": "2023/54",
      "scheme": "UKPGA",
      "uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents"
    },
    "lots": [
      {
        "id": "1",
        "status": "complete"
      }
    ],
    "procurementMethod": "open",
    "procurementMethodDetails": "Open procedure",
    "status": "complete",
    "techniques": {
      "frameworkAgreement": {
        "description": "Please refer to the ITO Documents for the Operation Description",
        "method": "withReopeningCompetition",
        "type": "closed"
      },
      "hasFrameworkAgreement": true
    },
    "title": "NHS National Framework for Transition products (Nilotinib and Ticagrelor)"
  }
}